The sensitivity of MIC-1 for diagnosis of CRC was better than that of CEA (43.8% vs 36.6%) and demonstrated comparable specificity (96.7% vs 95.9%), suggesting that MIC-1 can be used as a much more sensitive tumor serum biomarker compared to CEA for the detection of CRC. This evidence concerns the gene CEACAM5 and neoplasm.